Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4438) 4438
Book Chapter (85) 85
Newsletter (43) 43
Magazine Article (19) 19
Book / eBook (17) 17
Newspaper Article (5) 5
Dissertation (3) 3
Publication (2) 2
Conference Proceeding (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3693) 3693
science & technology (3052) 3052
life sciences & biomedicine (2906) 2906
animals (1713) 1713
female (1570) 1570
antibodies, monoclonal - therapeutic use (1366) 1366
biological and medical sciences (1322) 1322
male (1225) 1225
immunology (1158) 1158
medical sciences (1151) 1151
antibodies, anti-idiotypic - therapeutic use (968) 968
mice (935) 935
adult (930) 930
middle aged (836) 836
omalizumab (829) 829
antibodies, anti-idiotypic - immunology (825) 825
immunotherapy (749) 749
antibodies, monoclonal, humanized (573) 573
monoclonal antibodies (565) 565
antibodies, anti-idiotypic (563) 563
antibodies (546) 546
treatment outcome (543) 543
antibodies, monoclonal - immunology (534) 534
asthma - drug therapy (501) 501
allergy (492) 492
abridged index medicus (486) 486
aged (475) 475
oncology (445) 445
pharmacology. drug treatments (443) 443
antibodies, monoclonal, humanized - therapeutic use (375) 375
immunoglobulin e - immunology (368) 368
adolescent (362) 362
immunoglobulins (357) 357
fundamental and applied biological sciences. psychology (348) 348
asthma (339) 339
anti-asthmatic agents - therapeutic use (335) 335
antibodies, anti-idiotypic - blood (325) 325
child (322) 322
antigens (304) 304
anti-allergic agents - therapeutic use (299) 299
care and treatment (296) 296
health aspects (296) 296
enzyme-linked immunosorbent assay (295) 295
medicine, research & experimental (295) 295
research & experimental medicine (295) 295
pharmacology & pharmacy (279) 279
immunoglobulin g - immunology (278) 278
cancer (276) 276
research (273) 273
antineoplastic agents (251) 251
drug therapy (250) 250
asthma - immunology (248) 248
antibodies, monoclonal - adverse effects (243) 243
proteins (240) 240
analysis (237) 237
mice, inbred balb c (232) 232
antibodies, monoclonal - administration & dosage (230) 230
allergy and immunology (227) 227
tumors (226) 226
immunoglobulin e (224) 224
viral antibodies (222) 222
antibodies, anti-idiotypic - analysis (221) 221
clinical trials as topic (218) 218
immunoglobulin g (217) 217
t-lymphocytes - immunology (216) 216
antibodies, anti-idiotypic - biosynthesis (212) 212
immunopathology (212) 212
research article (207) 207
fundamental immunology (206) 206
antibody specificity (198) 198
hematology (196) 196
antigens, neoplasm - immunology (190) 190
disease models, animal (190) 190
autoimmunity (185) 185
biochemistry & molecular biology (184) 184
immunoglobulins, intravenous - therapeutic use (184) 184
medicine & public health (179) 179
rats (179) 179
young adult (178) 178
severity of illness index (177) 177
time factors (176) 176
immunoglobulin idiotypes - immunology (175) 175
immunoglobulin e - blood (174) 174
immunotherapy - methods (173) 173
rheumatology (170) 170
b-lymphocytes - immunology (167) 167
general & internal medicine (165) 165
allergies (162) 162
medicine (161) 161
respiratory system (160) 160
follow-up studies (158) 158
immunosuppressive agents - therapeutic use (157) 157
antibodies, anti-idiotypic - pharmacology (156) 156
antibodies, monoclonal - pharmacology (156) 156
autoantibodies - immunology (154) 154
immune system (152) 152
transplantation (152) 152
antibodies, anti-idiotypic - administration & dosage (151) 151
immunization (151) 151
medical research (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4438) 4438
French (55) 55
German (50) 50
Japanese (27) 27
Russian (26) 26
Spanish (22) 22
Chinese (12) 12
Italian (12) 12
Polish (10) 10
Dutch (7) 7
Danish (4) 4
Czech (3) 3
Turkish (3) 3
Croatian (2) 2
Hebrew (2) 2
Swedish (2) 2
Bulgarian (1) 1
Finnish (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
by van Schouwenburg, Pauline A and van de Stadt, Lotte A and de Jong, Rob N and van Buren, Esther E L and Kruithof, Simone and de Groot, Els and Hart, Margreet and van Ham, S Marieke and Rispens, Theo and Aarden, Lucien and Wolbink, Gerrit Jan and Wouters, Diana
Annals of the rheumatic diseases, ISSN 0003-4967, 01/2013, Volume 72, Issue 1, pp. 104 - 109
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Biological and medical sciences | Medical sciences | Immunomodulators | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Antibody Specificity | Antibodies, Monoclonal, Humanized - therapeutic use | Enzyme-Linked Immunosorbent Assay | Arthritis, Rheumatoid - blood | Antibodies, Anti-Idiotypic - blood | Humans | Antirheumatic Agents - immunology | Antibodies, Anti-Idiotypic - immunology | Antibodies, Neutralizing - immunology | Arthritis, Rheumatoid - drug therapy | Adalimumab | Antibodies, Monoclonal, Humanized - immunology | Antigen-Antibody Complex - immunology | Arthritis, Rheumatoid - immunology | Antibodies, Neutralizing - blood | Antirheumatic Agents - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Immune response | Tumor necrosis factor inhibitors | Rheumatoid arthritis | Dosage and administration | Product/Service Evaluations | Research | Drug therapy | Studies | Antigens | Tumor necrosis factor-TNF | Immunoglobulins | Patients | Binding sites | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders
by Könning, Doreen and Rhiel, Laura and Empting, Martin and Grzeschik, Julius and Sellmann, Carolin and Schröter, Christian and Zielonka, Stefan and Dickgießer, Stephan and Pirzer, Thomas and Yanakieva, Desislava and Becker, Stefan and Kolmar, Harald
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 9676 - 13
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antibodies, Anti-Idiotypic - genetics | Cetuximab - isolation & purification | Single-Domain Antibodies - metabolism | Saccharomyces cerevisiae - genetics | Antineoplastic Agents, Immunological - isolation & purification | Cetuximab - metabolism | Antibodies, Monoclonal, Humanized - metabolism | Antibodies, Anti-Idiotypic - metabolism | Antineoplastic Agents, Immunological - metabolism | Saccharomyces cerevisiae - metabolism | Immunomagnetic Separation | Antibodies, Monoclonal, Humanized - isolation & purification | Cell Surface Display Techniques | Protein Binding | Single-Domain Antibodies - genetics | Cancer vaccines | Immunoglobulins | Target recognition | Variable region | Monoclonal antibodies | Libraries | Drug development | Complementarity-determining region 3 | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Omalizumab for asthma in adults and children
by Normansell, Rebecca and Walker, Samantha and Milan, Stephen J and Walters, E. Haydn and Nair, Parameswaran and Walker, Samantha
Cochrane library, ISSN 1469-493X, 2014, Volume 2014, Issue 1, pp. CD003559 - CD003559
Pharmacological | Steroid sparing agents | Lungs & airways | Adrenal Cortex Hormones | Immunoglobulin E | Omalizumab | Anti‐Asthmatic Agents | Antibodies, Anti‐Idiotypic | Asthma (chronic): other medications | Insurance medicine | Return to Work | Antibodies, Monoclonal, Humanized | Asthma (chronic): steroid‐sparing | Injections, Subcutaneous | Asthma (chronic) | Child health | Asthma, chronic ‐ pharmacotherapy | Steroid‐sparing | Other medications | Allergic asthma | Allergy & intolerance | Asthma | Randomized Controlled Trials as Topic | Antibodies, monoclonal | Medicine General & Introductory Medical Sciences | Sick Leave | Chronic Disease | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Humans | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Immunoglobulin E - blood | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Immunoglobulin E - immunology | Asthma - immunology | Adult | Anti-Asthmatic Agents - administration & dosage | Antibodies, Anti-Idiotypic - therapeutic use | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study
by Hanania, Nicola A and Wenzel, Sally and Roseń, Karin and Hsieh, Hsin-Ju and Mosesova, Sofia and Choy, David F and Lal, Preeti and Arron, Joseph R and Harris, Jeffrey M and Busse, William
American journal of respiratory and critical care medicine, ISSN 1073-449X, 04/2013, Volume 187, Issue 8, pp. 804 - 811
Immunoglobulin E | Fractional exhaled nitric oxide | Severe asthma | Eosinophil | Periostin | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Omalizumab | Male | Nitric Oxide - analysis | Young Adult | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Adult | Female | Antibodies, Anti-Idiotypic - therapeutic use | Child | Cell Adhesion Molecules - blood | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Biomarkers - analysis | Breath Tests | Asthma - drug therapy | Asthma - genetics | Disease Progression | Adolescent | Aged | Anti-Asthmatic Agents - administration & dosage | Eosinophils | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A multifactorial screening strategy to identify anti-idiotypic reagents for bioanalytical support of antibody therapeutics
by Salimi-Moosavi, Hossein and Winters, Aaron and Abbott, Christina and Patel, Jennifer and Hager, Todd and Patel, Vimal and Shih, Judy and Zhuang, Yao and Ma, Mark
Analytical biochemistry, ISSN 0003-2697, 02/2015, Volume 470, pp. 52 - 60
Hybridoma | Ligand binding assay | Antibody screening | Anti-idiotypic | Bioanalysis | Reagent | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Antibodies, Neutralizing - immunology | Limit of Detection | Animals | Antibodies, Neutralizing - therapeutic use | Humans | Antibodies, Anti-Idiotypic - immunology | Indicators and Reagents | Ligands | Biological Assay - methods | Mice | Viral antibodies | Therapeutics | Antibodies | B cells | Homeopathy | Materia medica and therapeutics | Antigenic determinants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Long Survival of Patients with Small Cell Lung Cancer after Adjuvant Treatment with the Anti-Idiotypic Antibody BEC2 Plus Bacillus Calmette-Guérin
by Stefan C. Grant and Mark G. Kris and Alan N. Houghton and Paul B. Chapman
Clinical cancer research, ISSN 1078-0432, 06/1999, Volume 5, Issue 6, pp. 1319 - 1323
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Combined treatments (chemotherapy of immunotherapy associated with an other treatment) | Pharmacology. Drug treatments | Antibodies, Anti-Idiotypic - adverse effects | Immunoglobulin G - blood | Lung Neoplasms - mortality | Humans | Middle Aged | Immunotherapy, Active | Male | Survival Rate | Lung Neoplasms - therapy | Carcinoma, Small Cell - mortality | Gangliosides - immunology | Adjuvants, Immunologic - adverse effects | Carcinoma, Small Cell - immunology | Disease-Free Survival | Carcinoma, Small Cell - therapy | Lung Neoplasms - immunology | Immunoglobulin M - blood | Adult | Female | Aged | BCG Vaccine - therapeutic use | Adjuvants, Immunologic - therapeutic use | Antibodies, Anti-Idiotypic - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients
by Battaglia, Alessandra and Fossati, Marco and Buzzonetti, Alexia and Scambia, Giovanni and Fattorossi, Andrea
Immunology letters, ISSN 0165-2478, 11/2017, Volume 191, pp. 35 - 39
Predictive assay | Personalised treatment | Abagovomab | Interferon-γ | Immunotherapy | Ovarian cancer | Life Sciences & Biomedicine | Immunology | Science & Technology | CA-125 Antigen - immunology | Immunotherapy - methods | Lymphocyte Activation | Humans | Vaccination | Cells, Cultured | Ovarian Neoplasms - pathology | Antibodies, Monoclonal - therapeutic use | Membrane Proteins - immunology | Antineoplastic Agents - therapeutic use | Interferon-gamma - metabolism | Ovarian Neoplasms - mortality | Cancer Vaccines - immunology | Enterotoxins - immunology | Survival Analysis | Female | Immunocompetence | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Antibodies, Anti-Idiotypic - therapeutic use | Ovarian Neoplasms - drug therapy | Cancer patients | Care and treatment | Immune response | Monoclonal antibodies | T cells | Immune system | Medical research | Biological response modifiers | Medicine, Experimental | Interferon | Rankings | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Harnessing anti-idiotypic antibody alternatives to advance biotherapeutic pharmacokinetic assays
by Johnson, Matt
Bioanalysis, ISSN 1757-6180, 02/2020, Volume 12, Issue 3, pp. 125 - 128
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology
Journal Article
Details down arrow
9. Full Text Allergic bronchopulmonary aspergillosis and omalizumab
by Tillie‐Leblond, I and Germaud, P and Leroyer, C and Tétu, L and Girard, F and Devouassoux, G and Grignet, J.‐P and Prudhomme, A and Dusser, D and Wallaert, B
Allergy (Copenhagen), ISSN 0105-4538, 09/2011, Volume 66, Issue 9, pp. 1254 - 1256
allergic bronchopulmonary | asthma | aspergillus | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Omalizumab | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Aged | Prednisolone - therapeutic use | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Mycoses | Index Medicus | Anti-Asthmatic Agents | Anti-Inflammatory Agents | Aspergillosis, Allergic Bronchopulmonary | Life Sciences | Antibodies, Monoclonal, Humanized | Antibodies, Anti-Idiotypic | Prednisolone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
by MacGlashan, Donald W., MD, PhD and Saini, Sarbjit S., MD
Journal of allergy and clinical immunology, ISSN 0091-6749, 2013, Volume 132, Issue 4, pp. 906 - 911.e4
Allergy and Immunology | Human | Fc receptors | allergy | basophil | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Antibodies, Anti-Idiotypic - pharmacology | Humans | Middle Aged | Receptors, Fc - metabolism | Omalizumab | Antibodies, Monoclonal - therapeutic use | Male | Anti-Allergic Agents - pharmacology | Immunoglobulin E - blood | Young Adult | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Immunoglobulin E - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Basophils - immunology | Histamine Release | Hypersensitivity, Immediate - immunology | Adult | Female | Hypersensitivity, Immediate - therapy | Antibodies, Anti-Idiotypic - therapeutic use | Antibodies, Monoclonal - immunology | Basophils - drug effects | Anti-Allergic Agents - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Antibodies, Anti-Idiotypic - blood | Antibodies, Monoclonal - pharmacology | Antibodies, Anti-Idiotypic - immunology | Treatment Outcome | Anti-Allergic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Adolescent | Leukotriene C4 - metabolism | Antibodies, Monoclonal, Humanized - immunology | Anti-Allergic Agents - administration & dosage | Immunoglobulin E | Histamine | Studies | Antigens | Acids | Allergies | Index Medicus | Abridged Index Medicus | Fc Receptors | Basophil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights